Genomic risk model to implement precision prostate cancer screening in clinical care: theProGRESS study

Vassy JL Dornisch AM Karunamuni R Gatzen M Kachulis CJ Lennon NJ Brunette CA Danowski ME Hauger RL Garraway IP Kibel AS Lee KM Lynch JA Maxwell KN Ratner D Rose BS Teerlink CC Xu GJ Hofherr SE Lafferty KA Larkin K Malolepsza E Patterson CJ Toledo DM Donovan JL Hamdy FC Martin RM Neal DE Turner EL Andreassen OA Dale AM Mills IG Abraham A Batra J Clements J Cussenot O Cybulski C Eeles RA Fowke JH Grindedal EM Grönberg H Hamilton RJ Lim J Lu YJ MacInnis RJ Maier C Mucci LA Multigner L Neuhausen SL Nielsen SF Parent MÉ Park JY Petrovics G Plym A Razack A Rosenstein BS Schleutker J Sørensen KD Townsend PA Travis RC Vega A West CML Wiklund F Zheng W Seibert TM Profile SteeringCommittee IMPACT Study Steering Committee and Collaborators PRACTICAL Consortium VA Million VeteranProgram Seiber TM